Analysts See $1.60 EPS for ICON Public Limited Company (ICLR); Lamar Advertising Company – Class A (LAMR) Sellers Decreased By 15.04% Their Shorts

Lamar Advertising Company (NASDAQ:REIT) Logo

Analysts expect ICON Public Limited Company (NASDAQ:ICLR) to report $1.60 EPS on February, 21.They anticipate $0.17 EPS change or 11.89% from last quarter’s $1.43 EPS. ICLR’s profit would be $87.10M giving it 21.68 P/E if the $1.60 EPS is correct. After having $1.54 EPS previously, ICON Public Limited Company’s analysts see 3.90% EPS growth. The stock decreased 0.44% or $0.61 during the last trading session, reaching $138.76. About 284,071 shares traded. ICON Public Limited Company (NASDAQ:ICLR) has risen 25.12% since February 12, 2018 and is uptrending. It has outperformed by 25.12% the S&P500. Some Historical ICLR News: 17/04/2018 – ICON Announces Agreement With Intel Allowing Integration of the Intel(R) Pharma Analytics Platform for Clinical Trials; 02/05/2018 – Icon 1Q Rev $620.1M; 17/04/2018 – ICON Announces Agreement with Intel Allowing Integration of the lntel® Pharma Analytics Platform for Clinical Trials; 06/04/2018 – Icon Closes Below 200-Day Moving Average: Technicals; 17/04/2018 – ICON PACT W/INTEL ALLOWING INTEGRATION OF PHARMA ANALYTICS; 09/05/2018 – ICON Sponsors Industry-Wide Clinical Trials Survey to Support Transforming Trials Initiative; 30/05/2018 – Icon at Goldman Sachs Global Health Care Conference Jun 14; 18/04/2018 – Icon Presenting at Conference May 15; 02/05/2018 – ICON SEES FY EPS $5.91 TO $6.11, EST. $6.03; 02/04/2018 – Icon Closes Below 50-Day Moving Average: Technicals

Lamar Advertising Company – Class A (NASDAQ:LAMR) had a decrease of 15.04% in short interest. LAMR’s SI was 3.86 million shares in February as released by FINRA. Its down 15.04% from 4.55 million shares previously. With 671,000 avg volume, 6 days are for Lamar Advertising Company – Class A (NASDAQ:LAMR)’s short sellers to cover LAMR’s short positions. The SI to Lamar Advertising Company – Class A’s float is 4.61%. The stock decreased 0.09% or $0.07 during the last trading session, reaching $75.12. About 289,492 shares traded. Lamar Advertising Company (NASDAQ:REIT) has 0.00% since February 12, 2018 and is . It has by 0.00% the S&P500.

More notable recent ICON Public Limited Company (NASDAQ:ICLR) news were published by: Benzinga.com which released: “Benzinga’s Top Upgrades, Downgrades For January 25, 2019 – Benzinga” on January 25, 2019, also Nasdaq.com with their article: “Icon Breaks Below 200-Day Moving Average – Notable for ICLR – Nasdaq” published on November 19, 2018, Fool.com published: “How to Play It Safe in Biotech – The Motley Fool” on January 24, 2019. More interesting news about ICON Public Limited Company (NASDAQ:ICLR) were released by: Seekingalpha.com and their article: “ICON issues FY2019 guidance and reaffirms FY2018 guidance – Seeking Alpha” published on January 08, 2019 as well as Seekingalpha.com‘s news article titled: “Icon PLC’s (ICLR) CEO Steven Cutler on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: July 28, 2018.

Among 4 analysts covering Icon (NASDAQ:ICLR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Icon had 4 analyst reports since September 11, 2018 according to SRatingsIntel. The firm has “Overweight” rating by KeyBanc Capital Markets given on Tuesday, September 11. On Friday, January 25 the stock rating was upgraded by Mizuho to “Buy”. The firm earned “Outperform” rating on Tuesday, September 11 by Robert W. Baird. The company was upgraded on Friday, October 26 by Evercore.

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company has market cap of $7.55 billion. The firm specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It has a 24.96 P/E ratio. The Company’s clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services.

Since November 12, 2018, it had 0 insider buys, and 1 insider sale for $1.59 million activity. ISTRE KEITH A sold $1.59 million worth of stock or 20,791 shares.

More notable recent Lamar Advertising Company (NASDAQ:REIT) news were published by: Nasdaq.com which released: “Brookfield Property REIT Inc. Announces Commencement and Terms of Substantial Issuer Bid – Nasdaq” on February 11, 2019, also Nasdaq.com with their article: “Tier Reit (TIER) Q4 FFO and Revenues Surpass Estimates – Nasdaq” published on February 11, 2019, Nasdaq.com published: “Analysis: Positioning to Benefit within CSX, Apple Hospitality REIT, Sun Communities, News Corporation, Hub Group, and StoneMor Partners — Research Highlights Growth, Revenue, and Consolidated Results – Nasdaq” on February 11, 2019. More interesting news about Lamar Advertising Company (NASDAQ:REIT) were released by: Nasdaq.com and their article: “Why Senior Housing Properties Trust Is a Top 10 REIT Stock With 11.95% Yield (SNH) – Nasdaq” published on January 22, 2019 as well as Nasdaq.com‘s news article titled: “Near-Term Outlook for Retail REIT Stocks Looks Bleak – Nasdaq” with publication date: January 22, 2019.

ICON Public Limited Company (NASDAQ:ICLR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.